Chronic Pain Archives - Page 4 of 11

Cognitive Behavioral Therapy for Insomnia May Improve Sleep, Mood in Chronic Pain

By

July 30, 2019

The treatment of veterans with chronic pain and insomnia with cognitive behavioral therapy for insomnia may improve sleep and mood, but not pain.

Pediatrics Information Center

Peer Victimization May Predict Mood, Pain in Adolescents With Chronic Pain

By

Brandon May

July 4, 2019

Peer victimization may negatively affect mood and pain and may limit activity in youths with chronic pain.

Pain Information Center

Titanium Bone-Anchored Implants Used for the First Time to Repair Annular Defects During Diskectomies

By

Florence Chaverneff, Ph.D

June 24, 2019

For the first time in the United States, titanium bone-anchored implants were used to repair large annular defects during diskectomies.

Pain Information Center

Orthopedic Manual Physical Therapy May Not Enhance Biobehavioral Therapy in Chronic Low Back Pain

By

Clinical Advisor Contributing Writer

June 18, 2019

Orthopedic manual physical therapy, when combined with biobehavioral therapy, may not provide additional benefits to patients with chronic low back pain.

AAPA 2019 Annual Meeting

Short-Term Medical Marijuana Therapy for Chronic Pain

By

Rita Aghjayan

May 18, 2019

Short-term marijuana use may be more beneficial than long-term use for patients with chronic pain.

An immunotherapy treatment for gout is being tested for safety and efficacy.

Pain Information Center

Risk for Chronic Pain May Be Doubled in Patients With Gout

By

Gary Rothbard

May 13, 2019

A diagnosis of incident or new chronic pain may be twice as likely in patients with vs without gout.

Fibromyalgia is a syndrome characterized by chronic pain, stiffness, and tenderness of muscles, tendons, and joints without detectable inflammation. It affects an estimated 3 to 6 million Americans. Fibromyalgia is the second most common disorder seen by rheumatologists. It predominantly affects women at a rate of 3.4%, and less commonly, men at 0.5%, children at 1.2% to 6.2%, and the elderly. Prevalence increases with age, and diagnosis is most common between ages 60 and 79, although symptoms are often present years prior to diagnosis. It can occur independently or can be associated with another rheumatic disease, such as systemic lupus or rheumatoid arthritis.

Ob/Gyn Information Center

Menopause Symptoms Linked to Chronic Pain in Midlife

March 11, 2019

Menopause symptoms are associated with chronic pain among midlife female veterans.

Pain Information Center

Expert Panel Addresses Challenges to Implementing CDC Guideline on Prescribing Opioids

By

Tyler Rice

March 8, 2019

A panel of experts addressed several challenges associated with the implementation of the 2016 Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain.

Pain Management Information Center

Evidence of Therapeutic Efficacy Substantial for Cannabis Use

February 6, 2019

Substantial, conclusive evidence of therapeutic efficacy found for 85.5% of qualifying conditions.

A woman applying a topical analgesic for chronic pain

Pain Management Information Center

Compounded Topical Pain Creams No Better Than Placebo

February 6, 2019

At 1 month, no significant difference seen in positive outcomes for treatment vs control.

Diagnosis & Disease Information

Cognitive Behavioral Therapy for Insomnia May Improve Sleep, Mood in Chronic Pain

Peer Victimization May Predict Mood, Pain in Adolescents With Chronic Pain

Titanium Bone-Anchored Implants Used for the First Time to Repair Annular Defects During Diskectomies

Orthopedic Manual Physical Therapy May Not Enhance Biobehavioral Therapy in Chronic Low Back Pain

Short-Term Medical Marijuana Therapy for Chronic Pain

Risk for Chronic Pain May Be Doubled in Patients With Gout

Menopause Symptoms Linked to Chronic Pain in Midlife

Expert Panel Addresses Challenges to Implementing CDC Guideline on Prescribing Opioids

Evidence of Therapeutic Efficacy Substantial for Cannabis Use

Compounded Topical Pain Creams No Better Than Placebo

Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone